![]() | Only 14 pages are availabe for public view |
Abstract ABSTRACT Multiple sclerosis (MS) is a disease of the central nervous system (CNS), which affects the brain, spinal cord, and the optic nerves. MS does not directly affect the peripheral nerves. The usual age of onset is between 15 and 50, although cases have been reported to occur from the first to the eighth decades. MS attacks the myelinated axons in the CNS, destroying the myelin and the axons to varying degrees. The course of MS is highly varied and unpredictable. In most patients, the disease is characterized initially by episodes of reversible neurological deficits, which is often followed by progressive neurological deterioration over time. Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both according to center for disease control and health promotion (October 2019) which goes with multiple sclerosis. MS is the leading cause of non-traumatic neurological disability in young adults in the USA affecting about 149.2 cases for each 100,000 population Can mobile health applications provide a health education method for MS patients and a tool for assessment of patients’ compliance to medical treatment among MS patients of the Arabic speaking population? The use of mobile health apps can provide patient health safety and assurance via sense of being coated by the information and highly specialized physicians, improve health education via giving medical information suggesting that it will improve patients’ compliance to treatment, also decrease the response time between the patient and his doctor reaching to a satisfying limit. The information provided via the app will improve Multiple Sclerosis patients and their caregivers orientation and coping with MS. This was prospective comparative observational study that was conducted in Arabic speaking communities the study was conducted within a period of Six months with the use MS World mobile application and carried out on 100 Multiple sclerosis Patients that were divided into two groups: 50 study group using the app and 50 control group non app users. |